Exodus

Manufacturer
Bimeda Inc. | Bimeda-MTC Animal Health
Effective date
2023-12-13
Label type
OTC ANIMAL DRUG LABEL
Version
14
Source
full-release
Hydrated at
2026-06-01 02:42:39

Label at a glance#

ProductExodus
Active ingredientPYRANTEL PAMOATE
Label structure8 sections

Storage and handling

RECOMMENDED STORAGE : Store at 20°C-25°C (68°F-77°F); excursions permitted between 15°C-30°C (59°F-86°F).

Label contents#

Full prescribing information#

DESCRIPTION SECTION

Read Entire Carton Carefully Before Using This Product

DESCRIPTION:

Exodus® (pyrantel pamoate) Paste is a pale yellow to buff paste containing 43.9% w/w pyrantel pamoate in an inert vehicle. Each syringe contains 3.6 grams pyrantel base in 23.6 grams paste. Each mL contains 171 mg pyrantel base as pyrantel pamoate.

COMPONENTS

COMPOSITION:

Pyrantel pamoate is a compound belonging to a family classified chemically as tetrahydropyrimidines. It is a yellow, water-insoluble crystalline salt of the tetrahydropyrimidine base and pamoic acid containing 34.7% base activity. The chemical structure and name are given above.

CHEMICAL STRUCTURE:

image descriptionimage description

Chemical name: (E)-1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)-vinyl]-pyrimidine 4,4' methylenebis [3-hydroxy-2-naptholate] (1:1)

INDICATIONS & USAGE SECTION

INDICATIONS FOR USE:

For the removal and control of mature infections of large strongyles (Strongylus vulgaris, S. edentatus, S. equinus); small strongyles; pinworms (Oxyuris equi); and large roundworms (Parascaris equorum) in horses and ponies.

Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.

DOSAGE & ADMINISTRATION SECTION

DOSAGE AND TREATMENT:

Exodus® (pyrantel pamoate) Paste is to be administered as a single oral dose of 3 mg pyrantel base per lb of body weight. The syringe has 4 weight mark increments. Each weight mark indicates the recommended dose for 300 lb of body weight.

            DOSAGE

Body Weight Range

Volume

mg Pyrantel Base

up to 300 lb

¼ syringe

900 mg

301 – 600 lb

½ syringe

1800 mg

601 - 900 lb

¾ syringe

2700 mg

901 - 1200 lb

1 full syringe

3600 mg

Note: Position ring-gauge over appropriate mark on plunger. Each mL contains 171 mg of pyrantel base as pyrantel pamoate.

Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance.

For maximum control of parasitism, it is recommended that foals (2-8 months of age) be dosed every 4 weeks. To minimize the potential source of infection that the mare may pose to the foal, the mare should be treated 1 month prior to anticipated foaling date by retreatment 10 days to 2 weeks after birth of foal. Horses and ponies over 8 months of age should be routinely dosed every 6 weeks.

It is recommended that severely debilitated animals not be treated with this preparation.

ADMINISTRATION:

After removing the cap, the paste should be deposited on the dorsum of the tongue. Introduce the nozzle end of the syringe at the corner of the mouth. Direct the syringe backwards and depress the plunger to deposit the paste onto the tongue. Given in this manner, it is unlikely that rejection of the paste will occur. Raising the horse’s head sometimes assists in the swallowing process. When only part of the paste has been used, replace the cap on the syringe nozzle.

EFFICACY:

Critical (worm count) studies in horses demonstrated that pyrantel pamoate administered at the recommended dosage was efficacious against mature infections of Strongylus vulgaris (>90%), S. edentatus (69%), S. equinus (>90%), Oxyuris equi (81%), Parascaris equorum (>90%), and small strongyles (>90%).

WARNINGS SECTION

WARNINGS

For oral animal use only. Do not use in horses intended for human consumption.

HUMAN WARNINGS:

Keep out of the reach of children.

It is recommended that severely debilitated animals not be treated with this preparation.

OTHER WARNINGS: Parasite resistance may develop to any dewormer, and has been reported for most classes of dewormers. Treatment with a dewormer used in conjunction with parasite management practices appropriate to the geographic area and the animal(s) to be treated may slow the development of parasite resistance. Fecal examinations or other diagnostic tests and parasite management history should be used to determine if the product is appropriate for the herd prior to the use of any dewormer. Following the use of any dewormer, effectiveness of treatment should be monitored (for example, with the use of a fecal egg count reduction test or another appropriate method). A decrease in a drug's effectiveness over time as calculated by fecal egg count reduction tests may indicate the development of resistance to the dewormer administered. Your parasite management plan should be adjusted accordingly based on regular monitoring.

To report suspected adverse drug events, for technical assistance or to obtain a copy of the Safety Data Sheet (SDS), contact Bimeda, Inc. at 1-888-524-6332. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or online at www.fda.gov/reportanimalae.

STORAGE AND HANDLING SECTION

RECOMMENDED STORAGE: Store at 20°C-25°C (68°F-77°F); excursions permitted between 15°C-30°C (59°F-86°F).

SPL UNCLASSIFIED SECTION

Approved by FDA under ANADA # 200-350

Exodus®

(pyrantel pamoate) Paste

Horse Dewormer

Net Wt. 23.6 g

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image description
image description
image description
image description
image description
image description

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1433550Exodus 43.9 % Oral PastePSN14
1433543pyrantel pamoate 43.9 % Oral PastePSN14
1433550pyrantel pamoate 0.439 MG/MG Oral Paste [Exodus]SBD14
1433543pyrantel pamoate 0.439 MG/MG Oral PasteSCD14
1433550Exodus 0.439 MG/MG Oral PasteSY14
1433550Exodus 43.9 % Oral PasteSY14
1433543pyrantel pamoate 43.9 % Oral PasteSY14

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
61133-0141-1Exodus23.6 g in 1 SYRINGEPASTE23.614

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
61133-0141EXODUS (PYRANTEL PAMOATE) PASTE [BIMEDA INC.]141 package rows20231214_89b655f6-04df-41f6-bd66-e2a068dda5ff.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
PYRANTEL PAMOATEACTIVE INGREDIENT81BK194Z5M9
PYRANTELACTIVE MOIETY4QIH0N49E79

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
61133-014161133-0141-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
PYRANTEL PAMOATE81BK194Z5MACTIM

Source Document#

Source XML · Source PDF

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 16 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PINRIDPYRANTEL PAMOATEYYBA CORP59da86a4-db0d-4551-9128-e09a4e85cd782026-05-25WarningsName fallback
generic name: PYRANTEL PAMOATE
PINRIDPYRANTEL PAMOATEYYBA CORP52a9b5c8-08e6-b91e-e063-6294a90a0e0d2026-05-25WarningsName fallback
generic name: PYRANTEL PAMOATE
pinworm treatmentPYRANTEL PAMOATEBIONPHARMA INC.3cf96d04-e8bc-31af-e063-6294a90a0db82026-01-23WarningsName fallback
generic name: PYRANTEL PAMOATE
pinworm treatmentPYRANTEL PAMOATEAMERISOURCE BERGEN4837905f-1037-a319-e063-6294a90aba042026-01-21WarningsName fallback
generic name: PYRANTEL PAMOATE
Pyrantel PamoatePYRANTEL PAMOATEJefferson Labse862b337-2991-4b56-8584-fd80dccd725f2025-12-19WarningsName fallback
generic name: PYRANTEL PAMOATE
pinworm treatmentPYRANTEL PAMOATESTRATEGIC SOURCING SERVICES453c0645-f2b4-aa4a-e063-6294a90af1fb2025-12-05WarningsName fallback
generic name: PYRANTEL PAMOATE
LombrixPYRANTEL PAMOATEOPMX LLC3f940481-8e75-0bc7-e063-6394a90af1cd2025-09-24WarningsName fallback
generic name: PYRANTEL PAMOATE
PARASITOLPYRANTEL PAMOATEMenper Distributors Inc.cd5eb4c9-d0f0-4be7-84eb-88ebc4632dc62025-07-22WarningsName fallback
generic name: PYRANTEL PAMOATE
PINRIDPYRANTEL PAMOATEYYBA CORPfc225b5b-0ce8-4394-a643-39dbc674d7cd2025-07-02WarningsName fallback
generic name: PYRANTEL PAMOATE
MebendamaX PinwormPYRANTEL PAMOATEPharmadel LLC1d75b912-3550-7d4c-e063-6294a90ad5fa2025-06-18WarningsName fallback
generic name: PYRANTEL PAMOATE
Pyrantel PamoatePYRANTEL PAMOATEProMex LLCe68c503a-6f79-4f83-a6f3-c12a13fb06a02024-12-18WarningsName fallback
generic name: PYRANTEL PAMOATE
Pinworm MedicinePYRANTEL PAMOATEREESE PHARMACEUTICAL CO.f23d5092-48ca-46c4-830a-c34d0a3a7f572024-12-18WarningsName fallback
generic name: PYRANTEL PAMOATE
Walgreens Pinworm MedicinePYRANTEL PAMOATEWalgreens7fd58448-6846-4d8e-994c-d0ca2fd38e682024-12-18WarningsName fallback
generic name: PYRANTEL PAMOATE
CVS Pinworm TreatmentPYRANTEL PAMOATECVS PHARMACY INCd079008a-c87a-45f2-8775-0e40241761f02024-12-18WarningsName fallback
generic name: PYRANTEL PAMOATE
VRMX 500PYRANTEL PAMOATEOPMX LLCe119cad8-9814-7d5a-e053-2995a90afde52024-02-06WarningsName fallback
generic name: PYRANTEL PAMOATE
Pyrantel PamoatePYRANTEL PAMOATEProMex LLCe68dd24a-93f8-4e2e-a698-d9ad9a7cebac2018-01-02WarningsName fallback
generic name: PYRANTEL PAMOATE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.